Overview
Investigating the impact of p53 and SIRT1 in the development of type 2 DM
Description
Investigating the impact of p53 and SIRT1 in the development of type 2 DM through the treatment of prediabetic individuals by either nigetella salivata or Metformin
Eligibility
Inclusion Criteria:
- Prediabetic subjects.
Exclusion Criteria:
- Confirmed diabetes.
- Hepatic or renal impairment.